CRT-100.06 Differences in Quantitative Coronary Angiographic (QCA) Characteristics of Coronary Artery Disease and Clinical Outcomes Between Statin Pre-treated and Statin-Naïve Human Immunodeficiency Virus (HIV) Patients Undergoing Percutaneous Coronary Intervention (PCI)

Whereas statins are well-known to contribute to atheromatic plaque stability and regression of atherosclerosis burden, possible interactions with anti-retroviral therapy have led to sub-prescription in this cohort. However, exactly how statins affect the angiographic phenotype, coronary lesion